Site Map

Donovanosis (granuloma inguinale)

Granuloma inguinale; Sexually transmitted disease - donovanosis; STD - donovanosis; Sexually transmitted infection - donovanosis; STI - donovanosis

Donovanosis (granuloma inguinale) is a sexually transmitted disease (STD) that is rarely seen in the United States.

Images

I Would Like to Learn About:

Causes

Donovanosis is caused by the bacterium Klebsiella granulomatis. The disease is commonly found in tropical and subtropical areas such as southeast India, Guyana, and New Guinea. There are about 100 cases reported per year in the United States. Most of these cases occur in people who have traveled to or are from places where the disease is common.

The disease spreads mostly through vaginal or anal intercourse. Very rarely, it spreads during oral sex.

Most infections occur in people ages 20 to 40.

Symptoms

Symptoms can occur 1 to 12 weeks after coming in contact with the bacteria.

Symptoms may include:

• Sores in the anal area (in about half of cases)
• Small, beefy-red bumps on the genitals or around the anus

The skin gradually wears away, and the bumps turn into raised, beefy-red, velvety nodules called granulation tissue. They are often painless, but they bleed easily if injured. The disease slowly spreads and destroys genital tissue. Tissue damage may spread to the groin. The genitals and the skin around them lose skin color.

In its early stages, it may be hard to tell the difference between donovanosis and chancroid.

Exams and Tests

Tests may include:

• Culture of tissue sample (hard to do and not routinely available)
• Scrapings or biopsy of lesion

Laboratory tests for diagnosing donovanosis are available only on a research basis.

Treatment

Antibiotics are used to treat donovanosis. These may include:

• Azithromycin
• Doxycycline
• Ciprofloxacin
• Erythromycin
• Trimethoprim-sulfamethoxazole

To cure the condition, long-term treatment is needed. Most treatment courses require 3 weeks or until the sores have completely healed.

A follow-up exam is needed because the disease can reappear after it seems to be cured.

Outlook (Prognosis)

Early treatment helps prevent tissue damage or scarring. Untreated, the disease leads to damage of the genital tissue.

Possible Complications

Health problems that may result from this disease include:

• Genital damage and scarring
• Loss of skin color in the genital area
• Permanent genital swelling due to scarring

When to Contact a Medical Professional

Contact your health care provider for an appointment if:

• You have had sexual contact with a person who is known to have donovanosis
• You develop symptoms of donovanosis
• You develop an ulcer in the genital area

Prevention

Avoiding all sexual activity is the only absolute way to prevent an STD such as donovanosis. However, safer sex behaviors may reduce your risk.

The proper use of condoms, either the male or female type, greatly decreases the risk of catching an STD. You need to wear the condom from the beginning to the end of each sexual activity.

Related Information

Subcutaneous

References

Belda W. Granuloma inguinale (Donovanosis). In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 292.

Eckert LO, Lentz GM. Genital tract infections: vulva, vagina, cervix, toxic shock syndrome, endometritis, and salpingitis. In: Gershenson DM, Lentz GM, Valea FA, Lobo RA, eds. Comprehensive Gynecology. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 23.

Stoner BP, Reno HEL. Klebsiella granulomatis (donovanosis, granuloma inguinale). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 235.

BACK TO TOP

Review Date: 8/26/2023  

Reviewed By: Jatin M. Vyas, MD, PhD, Associate Professor in Medicine, Harvard Medical School; Associate in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

Health Content Provider 06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.